TE-6
Resource Report
Resource Website
|
BCRJ Cat# 0372, RRID:CVCL_1765
|
Homo sapiens (Human)
|
Esophageal squamous cell carcinoma
|
Population: Japanese., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:8509434
PMID:9096669
PMID:9290701
PMID:15172977
PMID:17804709
PMID:20164919
PMID:22460905
PMID:26589293
PMID:27397505
PMID:30894373
PMID:31068700
PMID:31978347
PMID:35839778
|
Cancer cell line
|
Male |
TE6 |
BCRJ |
0372 |
BTO:BTO_0002867,
CLO:CLO_0051376,
ArrayExpress:E-MTAB-783,
ArrayExpress:E-MTAB-2770,
ArrayExpress:E-MTAB-3610,
BCRJ:0372,
BioSample:SAMN03472040,
BioSample:SAMN10987703,
cancercelllines:CVCL_1765,
Cell_Model_Passport:SIDM00328,
CGH-DB:309-1,
CGH-DB:9259-4,
ChEMBL-Cells:CHEMBL3308180,
ChEMBL-Targets:CHEMBL2366144,
Cosmic:735785,
Cosmic:801327,
Cosmic:926102,
Cosmic:946355,
Cosmic:983718,
Cosmic:1123323,
Cosmic:1571758,
Cosmic:2698422,
Cosmic-CLP:946355,
DepMap:ACH-000605,
EGA:EGAS00001000978,
GDSC:946355,
GEO:GSM887700,
GEO:GSM888793,
GEO:GSM1670536,
LiGeA:CCLE_742,
LINCS_LDP:LCL-1570,
PharmacoDB:TE6_1583_2019,
PRIDE:PXD030304,
Progenetix:CVCL_1765,
PubChem_Cell_line:CVCL_1765,
RCB:RCB1950,
TKG:TKG 0257,
Wikidata:Q54972019 |
|
|
CVCL_1765 |
2026-07-25 05:03:13 |
0 |
TGW
Resource Report
Resource Website
|
JCRB Cat# JCRB0618, RRID:CVCL_1771
|
Homo sapiens (Human)
|
Adrenal gland neuroblastoma
|
Population: Japanese., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:2335222
PMID:12210830
PMID:15892104
PMID:18923524
PMID:20164919
PMID:27397505
PMID:30894373
PMID:30971826
PMID:35839778
|
Cancer cell line
|
Male |
TOG, TGW-nu, TGW-I-nu, TGW-nu-1 |
JCRB |
JCRB0618 |
CLO:CLO_0009830,
EFO:EFO_0022441,
ArrayExpress:E-MTAB-783,
ArrayExpress:E-MTAB-3610,
BioGRID_ORCS_Cell_line:1037,
BioSample:SAMN03471635,
cancercelllines:CVCL_1771,
Cell_Model_Passport:SIDM00324,
ChEMBL-Cells:CHEMBL3308792,
ChEMBL-Targets:CHEMBL1075600,
Cosmic:801749,
Cosmic:910780,
Cosmic:920238,
Cosmic:947703,
Cosmic:1037349,
Cosmic:1099146,
Cosmic:1153801,
Cosmic:2131589,
Cosmic-CLP:910780,
DepMap:ACH-001674,
EGA:EGAS00001000978,
GDSC:910780,
GEO:GSM314028,
GEO:GSM333815,
GEO:GSM1670542,
JCRB:JCRB0618,
LINCS_LDP:LCL-1962,
Lonza:1191,
PharmacoDB:TGW_1592_2019,
PRIDE:PXD030304,
Progenetix:CVCL_1771,
PubChem_Cell_line:CVCL_1771,
Wikidata:Q54972266 |
|
|
CVCL_1771 |
2026-07-25 05:03:17 |
0 |
TGW
Resource Report
Resource Website
|
RRID:CVCL_1771
|
Homo sapiens (Human)
|
Adrenal gland neuroblastoma
|
Population: Japanese., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:2335222
PMID:12210830
PMID:15892104
PMID:18923524
PMID:20164919
PMID:27397505
PMID:30894373
PMID:30971826
PMID:35839778
|
Cancer cell line
|
Male |
TOG, TGW-nu, TGW-I-nu, TGW-nu-1 |
|
|
CLO:CLO_0009830,
EFO:EFO_0022441,
ArrayExpress:E-MTAB-783,
ArrayExpress:E-MTAB-3610,
BioGRID_ORCS_Cell_line:1037,
BioSample:SAMN03471635,
cancercelllines:CVCL_1771,
Cell_Model_Passport:SIDM00324,
ChEMBL-Cells:CHEMBL3308792,
ChEMBL-Targets:CHEMBL1075600,
Cosmic:801749,
Cosmic:910780,
Cosmic:920238,
Cosmic:947703,
Cosmic:1037349,
Cosmic:1099146,
Cosmic:1153801,
Cosmic:2131589,
Cosmic-CLP:910780,
DepMap:ACH-001674,
EGA:EGAS00001000978,
GDSC:910780,
GEO:GSM314028,
GEO:GSM333815,
GEO:GSM1670542,
JCRB:JCRB0618,
LINCS_LDP:LCL-1962,
Lonza:1191,
PharmacoDB:TGW_1592_2019,
PRIDE:PXD030304,
Progenetix:CVCL_1771,
PubChem_Cell_line:CVCL_1771,
Wikidata:Q54972266 |
|
|
CVCL_1771 |
2026-07-25 05:03:17 |
0 |
MDA-MB-175-VII
Resource Report
Resource Website
10+ mentions
|
RRID:CVCL_1400
|
Homo sapiens (Human)
|
Invasive breast carcinoma of no special type
|
Population: African American., Part of: MD Anderson Cell Lines Project., Part of: JWGray breast cancer cell line panel., Part of: ICBP43 breast cancer cell line panel., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:730202
PMID:3518877
PMID:4412247
PMID:10969801
PMID:11044355
PMID:12353263
PMID:12800145
PMID:15677628
PMID:16397213
PMID:16541312
PMID:17157791
PMID:19582160
PMID:19593635
PMID:20070913
PMID:20164919
PMID:20215515
PMID:20407441
PMID:22460905
PMID:23601657
PMID:24094812
PMID:24176112
PMID:25485619
PMID:25877200
PMID:25960936
PMID:26589293
PMID:28196595
PMID:28889351
PMID:29610121
PMID:30894373
PMID:31068700
PMID:35839778
|
Cancer cell line
|
Female |
MDA MB 175 VII, MDA-MB-175VII, MDAMB175VII, MDA-MB-175, MDAMB175, MDA-175, MDA175, MD Anderson-Metastatic Breast-175-VII |
|
|
BTO:BTO_0003471,
CLO:CLO_0007633,
EFO:EFO_0001208,
AddexBio:C0006009/4885,
ArrayExpress:E-MTAB-38,
ArrayExpress:E-MTAB-783,
ArrayExpress:E-MTAB-2706,
ArrayExpress:E-MTAB-2770,
ArrayExpress:E-TABM-157,
ATCC:HTB-25,
BioSample:SAMN03472690,
BioSample:SAMN10987665,
cancercelllines:CVCL_1400,
CCRID:1101HUM-PUMC000349,
Cell_Model_Passport:SIDM00633,
ChEMBL-Cells:CHEMBL3308404,
ChEMBL-Targets:CHEMBL1075497,
CLS:305825,
Cosmic:687493,
Cosmic:809236,
Cosmic:871145,
Cosmic:894086,
Cosmic:897422,
Cosmic:904376,
Cosmic:908120,
Cosmic:934526,
Cosmic:997917,
Cosmic:1010931,
Cosmic:1044227,
Cosmic:1046955,
Cosmic:1047690,
Cosmic:1176646,
Cosmic:1287894,
Cosmic:1289394,
Cosmic:1309001,
Cosmic:1434951,
Cosmic:1603218,
Cosmic:1609470,
Cosmic:2165025,
Cosmic:2750525,
Cosmic-CLP:908120,
DepMap:ACH-000759,
EGA:EGAS00001000610,
GDSC:908120,
GEO:GSM115106,
GEO:GSM217586,
GEO:GSM219930,
GEO:GSM320175,
GEO:GSM344348,
GEO:GSM344398,
GEO:GSM350511,
GEO:GSM421872,
GEO:GSM466359,
GEO:GSM783950,
GEO:GSM844592,
GEO:GSM844593,
GEO:GSM847400,
GEO:GSM847493,
GEO:GSM887294,
GEO:GSM888369,
GEO:GSM1053731,
GEO:GSM1172888,
GEO:GSM1172978,
GEO:GSM1238134,
GEO:GSM1374650,
IARC_TP53:21080,
IGRhCellID:MDAMB175VII,
LiGeA:CCLE_228,
LINCS_HMS:50329,
LINCS_LDP:LCL-1317,
NCBI_Iran:C432,
PharmacoDB:MDAMB175VII_899_2019,
PRIDE:PXD030304,
Progenetix:CVCL_1400,
PubChem_Cell_line:CVCL_1400,
SLKBase:3590,
Wikidata:Q54904579 |
|
|
CVCL_1400 |
2026-07-25 04:49:23 |
19 |
MDA-MB-435
Resource Report
Resource Website
500+ mentions
Contaminated
Contaminated
Possibly Discontinued
|
RRID:CVCL_0417
|
Homo sapiens (Human)
|
Amelanotic melanoma
|
Miscellaneous: Formerly the CCRID database had an entry describing this cell line (3111C0001CCC000351). It was one of the sources for the STR profile of this entry., Population: Caucasian., Part of: NCI-60 cancer cell line panel., Part of: JWGray breast cancer cell line panel., Problematic cell line: Contaminated. Shown to be a M14 derivative (PubMed=17004106; PubMed=18304946; PubMed=20143388; PubMed=28940260). Originally thought to originate from the pleural effusion of a breast carcinoma from a 31 year old patient. See also PubMed=19549886 for a dissenting but incorrect view that states that M14 is a breast cancer cell line..
|
PMID:730202
PMID:7272986
PMID:9331090
PMID:10700174
PMID:10969801
PMID:11044355
PMID:15153330
PMID:15748285
PMID:17004106
PMID:17088437
PMID:17157791
PMID:18304946
PMID:19372543
PMID:19549886
PMID:20143388
PMID:20164919
PMID:22068913
PMID:22347499
PMID:22384151
PMID:22628656
PMID:23856246
PMID:23933261
PMID:24094812
PMID:24162158
PMID:24279929
PMID:24670534
PMID:25485619
PMID:25877200
PMID:26589293
PMID:27377824
PMID:27397505
PMID:27807467
PMID:28721362
PMID:28889351
PMID:28940260
PMID:31733513
PMID:38861359
|
Cancer cell line
|
Male |
MDA-MB435, MDAMB435, MDA.MB.435, MDA-435, MDA 435, MDA435, MD Anderson-Metastatic Breast-435 |
|
|
BTO:BTO_0001567,
EFO:EFO_0001213,
MCCL:MCC:0000314,
ArrayExpress:E-MTAB-783,
ArrayExpress:E-MTAB-2706,
ArrayExpress:E-TABM-157,
BioSample:SAMN03151832,
BioSample:SAMN03470861,
cancercelllines:CVCL_0417,
Cell_Model_Passport:SIDM00004,
ChEMBL-Cells:CHEMBL3307686,
ChEMBL-Targets:CHEMBL614697,
Cosmic:687496,
Cosmic:875879,
Cosmic:905988,
Cosmic:974069,
Cosmic:974236,
Cosmic:991325,
Cosmic:1000131,
Cosmic:1010930,
Cosmic:1044219,
Cosmic:1092614,
Cosmic:1175834,
Cosmic:1176643,
Cosmic:1219445,
Cosmic:1305366,
Cosmic:1312349,
Cosmic:1477425,
Cosmic:1524346,
Cosmic:1571794,
Cosmic:1945861,
Cosmic:1998456,
EGA:EGAS00001000610,
EGA:EGAS00001002554,
GEO:GSM2095,
GEO:GSM50203,
GEO:GSM50265,
GEO:GSM206523,
GEO:GSM274648,
GEO:GSM274649,
GEO:GSM344352,
GEO:GSM344402,
GEO:GSM383801,
GEO:GSM383802,
GEO:GSM383803,
GEO:GSM743466,
GEO:GSM750814,
GEO:GSM783965,
GEO:GSM799354,
GEO:GSM799417,
GEO:GSM844589,
GEO:GSM844590,
GEO:GSM847037,
GEO:GSM1008908,
GEO:GSM1153424,
GEO:GSM1178391,
GEO:GSM1178392,
GEO:GSM1181294,
GEO:GSM1181337,
GEO:GSM1215267,
GEO:GSM1670084,
GEO:GSM2124670,
IARC_TP53:18065,
NCI-DTP:MDA-MB-435,
PharmacoDB:MDAMB435_904_2019,
PRIDE:PXD003539,
PRIDE:PXD005942,
PRIDE:PXD005946,
Progenetix:CVCL_0417,
PubChem_Cell_line:CVCL_0417,
SKY/M-FISH/CGH:2816,
TOKU-E:3544,
Wikidata:Q50952937 |
cvcl_1395 |
|
CVCL_0417 |
2026-07-25 04:49:25 |
889 |
MDA-MB-415
Resource Report
Resource Website
1+ mentions
|
RRID:CVCL_0621
|
Homo sapiens (Human)
|
Breast adenocarcinoma
|
Part of: MD Anderson Cell Lines Project., Part of: JWGray breast cancer cell line panel., Part of: ICBP43 breast cancer cell line panel., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE)., Part of: AKT genetic alteration cell panel (ATCC TCP-1029).
|
PMID:730202
PMID:6935474
PMID:7272986
PMID:9331070
PMID:10969801
PMID:11343771
PMID:12800145
PMID:16397213
PMID:16541312
PMID:17157791
PMID:18516279
PMID:19593635
PMID:20070913
PMID:20164919
PMID:22460905
PMID:23601657
PMID:24094812
PMID:24162158
PMID:24176112
PMID:25485619
PMID:25877200
PMID:26589293
PMID:27397505
PMID:28196595
PMID:28889351
PMID:30894373
PMID:30971826
PMID:31068700
PMID:35839778
|
Cancer cell line
|
Female |
MDA-MB415, MDAMB415, MDA-415, MDA415, MD Anderson-Metastatic Breast-415 |
|
|
BTO:BTO_0006039,
CLO:CLO_0007637,
EFO:EFO_0001212,
CLDB:cl3407,
CLDB:cl7127,
ArrayExpress:E-MTAB-783,
ArrayExpress:E-MTAB-2706,
ArrayExpress:E-MTAB-2770,
ArrayExpress:E-MTAB-3610,
ArrayExpress:E-TABM-157,
ArrayExpress:E-TABM-244,
ATCC:HTB-128,
BioGRID_ORCS_Cell_line:555,
BioSample:SAMN03471279,
BioSample:SAMN10988336,
cancercelllines:CVCL_0621,
CCRID:1101HUM-PUMC000350,
CCRID:3101HUMTCHu175,
Cell_Model_Passport:SIDM00630,
ChEMBL-Cells:CHEMBL3308760,
ChEMBL-Targets:CHEMBL1075498,
CLS:305129,
Cosmic:871148,
Cosmic:894088,
Cosmic:897424,
Cosmic:904380,
Cosmic:924240,
Cosmic:949190,
Cosmic:1010917,
Cosmic:1027054,
Cosmic:1044225,
Cosmic:1046928,
Cosmic:1047697,
Cosmic:1090334,
Cosmic:1136348,
Cosmic:1176650,
Cosmic:1287896,
Cosmic:1289398,
Cosmic:1434954,
Cosmic:1502207,
Cosmic:1603221,
Cosmic:1609460,
Cosmic:2165026,
Cosmic:2301530,
Cosmic:2750527,
Cosmic-CLP:924240,
DepMap:ACH-000876,
EGA:EGAS00001000610,
EGA:EGAS00001000978,
GDSC:924240,
GEO:GSM115101,
GEO:GSM149982,
GEO:GSM149990,
GEO:GSM149998,
GEO:GSM186440,
GEO:GSM186441,
GEO:GSM217588,
GEO:GSM344351,
GEO:GSM344401,
GEO:GSM421876,
GEO:GSM783953,
GEO:GSM844596,
GEO:GSM844597,
GEO:GSM844598,
GEO:GSM844599,
GEO:GSM847415,
GEO:GSM847495,
GEO:GSM887297,
GEO:GSM888372,
GEO:GSM1008907,
GEO:GSM1053714,
GEO:GSM1172981,
GEO:GSM1215266,
GEO:GSM1238122,
GEO:GSM1374656,
GEO:GSM1670083,
IARC_TP53:24355,
ICLC:HTL02005,
LiGeA:CCLE_116,
LINCS_HMS:50332,
LINCS_LDP:LCL-1469,
Lonza:1252,
PharmacoDB:MDAMB415_903_2019,
PRIDE:PXD002486,
PRIDE:PXD030304,
Progenetix:CVCL_0621,
PubChem_Cell_line:CVCL_0621,
SLKBase:3604,
Ubigene:YC-D007,
Wikidata:Q54904630 |
|
|
CVCL_0621 |
2026-07-25 04:49:25 |
9 |
MDA-MB-361
Resource Report
Resource Website
500+ mentions
|
RRID:CVCL_0620
|
Homo sapiens (Human)
|
Breast adenocarcinoma
|
Population: Caucasian., Part of: PI3K genetic alteration cell panel (ATCC TCP-1028)., Part of: MD Anderson Cell Lines Project., Part of: KuDOS 95 cell line panel., Part of: JWGray breast cancer cell line panel., Part of: ICBP43 breast cancer cell line panel., Part of: EGFR genetic alteration cell panel (ATCC TCP-1027)., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:730202
PMID:833871
PMID:3518877
PMID:6935474
PMID:7272986
PMID:9671407
PMID:10862037
PMID:10969801
PMID:11044355
PMID:11343771
PMID:12800145
PMID:15677628
PMID:16397213
PMID:16541312
PMID:17157791
PMID:17334996
PMID:18516279
PMID:19582160
PMID:19593635
PMID:20070913
PMID:20164919
PMID:20215515
PMID:22460905
PMID:22585861
PMID:23601657
PMID:24094812
PMID:24176112
PMID:25485619
PMID:25877200
PMID:25960936
PMID:26589293
PMID:27397505
PMID:28196595
PMID:28889351
PMID:29273624
PMID:30894373
PMID:30971826
PMID:31068700
PMID:35839778
|
Cancer cell line
|
Female |
MDA-MB 361, MDA MB 361, MDA-MB361, MDAMB361, MDA-361, MDA361, MB361, MD Anderson-Metastatic Breast-361 |
|
|
BTO:BTO_0001569,
CLO:CLO_0007636,
EFO:EFO_0001211,
CLDB:cl3406,
ArrayExpress:E-MTAB-783,
ArrayExpress:E-MTAB-2706,
ArrayExpress:E-MTAB-2770,
ArrayExpress:E-MTAB-3610,
ArrayExpress:E-TABM-157,
ArrayExpress:E-TABM-244,
ATCC:HTB-27,
BCRC:60549,
BioGRID_ORCS_Cell_line:1048,
BioSample:SAMN03472909,
BioSample:SAMN10987900,
cancercelllines:CVCL_0620,
CCRID:1101HUM-PUMC000381,
Cell_Model_Passport:SIDM00528,
ChEMBL-Cells:CHEMBL3308405,
ChEMBL-Targets:CHEMBL614129,
CLS:305267,
Cosmic:687495,
Cosmic:809235,
Cosmic:871147,
Cosmic:904379,
Cosmic:908121,
Cosmic:934527,
Cosmic:979709,
Cosmic:997919,
Cosmic:1000124,
Cosmic:1010928,
Cosmic:1017160,
Cosmic:1018464,
Cosmic:1046933,
Cosmic:1047695,
Cosmic:1136355,
Cosmic:1176627,
Cosmic:1287895,
Cosmic:1289397,
Cosmic:1308994,
Cosmic:1348961,
Cosmic:1434953,
Cosmic:1523777,
Cosmic:1603220,
Cosmic:1609461,
Cosmic:2165011,
Cosmic:2301529,
Cosmic-CLP:908121,
DepMap:ACH-000934,
ECACC:92020423,
EGA:EGAS00001000610,
EGA:EGAS00001000978,
EGA:EGAS00001002554,
GDSC:908121,
GEO:GSM73751,
GEO:GSM115119,
GEO:GSM155208,
GEO:GSM186437,
GEO:GSM186438,
GEO:GSM186439,
GEO:GSM217587,
GEO:GSM274655,
GEO:GSM344350,
GEO:GSM344400,
GEO:GSM350546,
GEO:GSM421875,
GEO:GSM481306,
GEO:GSM783952,
GEO:GSM827280,
GEO:GSM847402,
GEO:GSM847494,
GEO:GSM887296,
GEO:GSM888371,
GEO:GSM1008906,
GEO:GSM1053728,
GEO:GSM1172890,
GEO:GSM1172980,
GEO:GSM1238121,
GEO:GSM1264070,
GEO:GSM1264072,
GEO:GSM1264112,
GEO:GSM1264114,
GEO:GSM1374653,
GEO:GSM1374654,
GEO:GSM1374655,
GEO:GSM1401664,
GEO:GSM1670082,
GEO:GSM2258758,
GEO:GSM2258759,
GEO:GSM2258760,
GEO:GSM2258761,
GEO:GSM2258762,
GEO:GSM2258763,
GEO:GSM2258764,
GEO:GSM2258765,
GEO:GSM2258766,
GEO:GSM2258767,
GEO:GSM2258768,
GEO:GSM2258769,
GEO:GSM2258770,
GEO:GSM2258771,
GEO:GSM2258772,
GEO:GSM2258773,
GEO:GSM2258774,
GEO:GSM2258775,
GEO:GSM2258935,
GEO:GSM2258936,
GEO:GSM2258937,
IARC_TP53:18373,
IARC_TP53:21128,
LiGeA:CCLE_872,
LINCS_HMS:50331,
LINCS_LDP:LCL-1468,
NCBI_Iran:C433,
PharmacoDB:MDAMB361_902_2019,
PRIDE:PXD030304,
Progenetix:CVCL_0620,
PubChem_Cell_line:CVCL_0620,
SLKBase:3600,
Wikidata:Q54904626 |
|
|
CVCL_0620 |
2026-07-25 04:49:25 |
516 |
ME-180
Resource Report
Resource Website
100+ mentions
Discontinued
|
RRID:CVCL_1401
|
Homo sapiens (Human)
|
Human papillomavirus-related cervical squamous cell carcinoma
|
Virology: Contains a complete HPV68 genome., Population: Caucasian., Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982)., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:77569
PMID:327080
PMID:833871
PMID:2990217
PMID:3371749
PMID:3518877
PMID:4317734
PMID:6220172
PMID:6500159
PMID:6582512
PMID:7017212
PMID:7459858
PMID:7751322
PMID:8380785
PMID:8931502
PMID:9290701
PMID:9887230
PMID:15531914
PMID:17325662
PMID:20164919
PMID:20215515
PMID:22710073
PMID:24134916
PMID:25485619
PMID:25877200
PMID:26589293
PMID:27397505
PMID:27561551
PMID:29156801
PMID:30894373
PMID:35839778
|
Cancer cell line
|
Female |
Me-180, ME 180, ME180 |
|
|
CLO:CLO_0007657,
CLO:CLO_0050924,
EFO:EFO_0006646,
CLDB:cl3429,
ArrayExpress:E-MTAB-783,
ArrayExpress:E-MTAB-2706,
ArrayExpress:E-MTAB-3610,
ATCC:CRL-7932,
ATCC:HTB-33,
BioSample:SAMN03471125,
BioSample:SAMN03472007,
BioSample:SAMN03472511,
BioSample:SAMN03473047,
cancercelllines:CVCL_1401,
CCRID:3101HUMTCHu177,
Cell_Model_Passport:SIDM00627,
ChEMBL-Cells:CHEMBL3308114,
ChEMBL-Targets:CHEMBL1075499,
CLS:300196,
Cosmic:687514,
Cosmic:760223,
Cosmic:809228,
Cosmic:846185,
Cosmic:877466,
Cosmic:928909,
Cosmic:1071909,
Cosmic:1102582,
Cosmic:1131524,
Cosmic:1175837,
Cosmic:1176609,
Cosmic:1193031,
Cosmic:1995503,
Cosmic:2301541,
Cosmic:2546868,
Cosmic:2660192,
Cosmic:2816215,
Cosmic-CLP:687514,
DepMap:ACH-001359,
EGA:EGAS00001000610,
EGA:EGAS00001000978,
FANTOM5_SSTAR:10553-107I4,
GDSC:687514,
GEO:GSM113864,
GEO:GSM253300,
GEO:GSM595618,
GEO:GSM675736,
GEO:GSM685436,
GEO:GSM827202,
GEO:GSM1670090,
IARC_TP53:21490,
ICLC:HTL96027,
IGRhCellID:ME180%20GEO,
JCRB:JCRB0810,
KCLB:30033,
LINCS_LDP:LCL-1305,
PharmacoDB:ME180_910_2019,
PRIDE:PXD003668,
PRIDE:PXD030304,
Progenetix:CVCL_1401,
PubChem_Cell_line:CVCL_1401,
RCB:RCB2106,
TKG:TKG 0437,
TOKU-E:2410,
Wikidata:Q54904901 |
|
|
CVCL_1401 |
2026-07-25 04:49:33 |
170 |
MEG-01
Resource Report
Resource Website
100+ mentions
|
RRID:CVCL_0425
|
Homo sapiens (Human)
|
Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
|
Characteristics: Can be induced to differentiate into megakaryocytes after application of 12-O-tetradecanoyl-13-phorbol acetate (TPA) or valproic acid (VPA) (PubMed=1742484; PubMed=30332548)., Population: Japanese., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:1742484
PMID:2998511
PMID:3332852
PMID:9738977
PMID:10071072
PMID:10576511
PMID:15843827
PMID:20164919
PMID:20215515
PMID:20809971
PMID:22460905
PMID:26700326
PMID:27277069
PMID:27397505
PMID:30285677
PMID:30332548
PMID:30629668
PMID:30894373
PMID:31068700
PMID:32180119
PMID:35839778
PMID:36982453
|
Cancer cell line
|
Male |
Meg-01, MEG01, Meg01 |
|
|
BTO:BTO_0002581,
CLO:CLO_0007668,
EFO:EFO_0002232,
MCCL:MCC:0000322,
CLDB:cl3432,
CLDB:cl3433,
ArrayExpress:E-MTAB-38,
ArrayExpress:E-MTAB-783,
ArrayExpress:E-MTAB-2770,
ArrayExpress:E-MTAB-3610,
ATCC:CRL-2021,
BCRC:60238,
BCRJ:0262,
BioSample:SAMN01821577,
BioSample:SAMN01821648,
BioSample:SAMN01821734,
BioSample:SAMN03471278,
BioSample:SAMN10988184,
cancercelllines:CVCL_0425,
CCRID:1101HUM-PUMC000521,
CCRID:3101HUMTCHu197,
Cell_Model_Passport:SIDM00526,
ChEMBL-Cells:CHEMBL3308539,
ChEMBL-Targets:CHEMBL2366084,
CLS:300482,
Cosmic:787503,
Cosmic:908126,
Cosmic:924042,
Cosmic:1026578,
Cosmic:1070702,
Cosmic:1078723,
Cosmic:1516634,
Cosmic:1523830,
Cosmic-CLP:908126,
DepMap:ACH-000072,
DSMZ:ACC-364,
DSMZCellDive:ACC-364,
ECACC:94012401,
EGA:EGAS00001000978,
FANTOM5_SSTAR:10752-110D5,
GDSC:908126,
GEO:GSM482498,
GEO:GSM887307,
GEO:GSM888383,
GEO:GSM1374669,
GEO:GSM1670093,
IARC_TP53:21491,
ICLC:HTL96017,
IGRhCellID:MEG01,
JCRB:IFO50151,
LiGeA:CCLE_381,
LINCS_LDP:LCL-1110,
Lonza:959,
PharmacoDB:MEG01_913_2019,
PRIDE:PXD030304,
Progenetix:CVCL_0425,
PubChem_Cell_line:CVCL_0425,
Wikidata:Q54905035 |
|
|
CVCL_0425 |
2026-07-25 04:49:37 |
153 |
Mel JuSo
Resource Report
Resource Website
10+ mentions
|
RRID:CVCL_1403
|
Homo sapiens (Human)
|
Cutaneous melanoma
|
Population: Caucasian., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:2174414
PMID:6895502
PMID:9598804
PMID:10766161
PMID:11668190
PMID:15009714
PMID:18698037
PMID:20164919
PMID:22460905
PMID:25877200
PMID:26589293
PMID:27397505
PMID:30894373
PMID:31068700
PMID:31978347
PMID:35839778
|
Cancer cell line
|
Female |
MEL-Juso, MEL-JUSO, Mel-Juso, Mel Juso, MelJuSo, MELJUSO, JuSo |
|
|
BTO:BTO_0001588,
CLO:CLO_0007676,
EFO:EFO_0022434,
EFO:EFO_0022720,
CLDB:cl3440,
ArrayExpress:E-MTAB-783,
ArrayExpress:E-MTAB-2770,
ArrayExpress:E-MTAB-3610,
BioGRID_ORCS_Cell_line:548,
BioSample:SAMN03471884,
BioSample:SAMN10988249,
cancercelllines:CVCL_1403,
Cell_Model_Passport:SIDM00336,
ChEMBL-Cells:CHEMBL3308761,
ChEMBL-Targets:CHEMBL1075501,
CLS:300282,
Cosmic:706091,
Cosmic:888060,
Cosmic:888835,
Cosmic:897474,
Cosmic:908125,
Cosmic:1020272,
Cosmic:1022285,
Cosmic:1459306,
Cosmic:1995505,
Cosmic-CLP:908125,
DepMap:ACH-000881,
DSMZ:ACC-74,
DSMZCellDive:ACC-74,
EGA:EGAS00001000978,
GDSC:908125,
GEO:GSM887309,
GEO:GSM888385,
GEO:GSM1374670,
GEO:GSM1670095,
IARC_TP53:21493,
LiGeA:CCLE_674,
LINCS_LDP:LCL-1252,
PharmacoDB:MELJUSO_915_2019,
PRIDE:PXD011899,
PRIDE:PXD019519,
PRIDE:PXD021877,
PRIDE:PXD030304,
Progenetix:CVCL_1403,
PubChem_Cell_line:CVCL_1403,
Wikidata:Q54905064 |
|
|
CVCL_1403 |
2026-07-25 04:49:39 |
24 |
MFH-ino
Resource Report
Resource Website
|
RRID:CVCL_1407
|
Homo sapiens (Human)
|
Undifferentiated pleomorphic sarcoma
|
Population: Japanese., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:1653597
PMID:20164919
PMID:27397505
PMID:30894373
PMID:35839778
|
Cancer cell line
|
Female |
MFH-INO, MFHINO |
|
|
CLO:CLO_0050084,
ArrayExpress:E-MTAB-783,
ArrayExpress:E-MTAB-3610,
BioSample:SAMN03472224,
cancercelllines:CVCL_1407,
Cell_Model_Passport:SIDM00299,
ChEMBL-Cells:CHEMBL3308269,
ChEMBL-Targets:CHEMBL2366262,
Cosmic:925343,
Cosmic-CLP:925343,
DepMap:ACH-002271,
EGA:EGAS00001000978,
FANTOM5_SSTAR:10600-108E6,
GDSC:925343,
GEO:GSM1670101,
IARC_TP53:27563,
LINCS_LDP:LCL-1753,
PharmacoDB:MFHino_922_2019,
PRIDE:PXD030304,
PubChem_Cell_line:CVCL_1407,
RCB:RCB0749,
Wikidata:Q54905391 |
|
|
CVCL_1407 |
2026-07-25 04:49:47 |
0 |
MG-63
Resource Report
Resource Website
1000+ mentions
|
RRID:CVCL_0426
|
Homo sapiens (Human)
|
Osteosarcoma
|
Caution: The reported STR profile from CLS of this cell line was changed in June 2019. Seven conflicts with other sources were resolved., Anecdotal: Have been flown in space on Foton-10 and Foton-M3 to study if differentiation is altered in microgravity (PubMed=9144345; PubMed=9600771; PubMed=24903274)., Characteristics: Can be induced to differentiate by treating the cells with 1,25-dihydroxyvitamin D3 and TGF-beta. The cells do not differentiate into the mineralized state, but stop at the matrix maturation stage (PubMed=1577731)., Population: Caucasian., Part of: MD Anderson Cell Lines Project., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE)., Group: Space-flown cell line (cellonaut).
|
PMID:218153
PMID:883813
PMID:1577731
PMID:2233717
PMID:2823272
PMID:7873286
PMID:8617485
PMID:9144345
PMID:9600771
PMID:12645653
PMID:15736406
PMID:17981215
PMID:19160414
PMID:19363654
PMID:19787792
PMID:20164919
PMID:20215515
PMID:21519327
PMID:22460905
PMID:23129384
PMID:23144859
PMID:24903274
PMID:25382592
PMID:25485619
PMID:25877200
PMID:26320182
PMID:26589293
PMID:27397505
PMID:28196595
PMID:29334376
PMID:30894373
PMID:31068700
PMID:35839778
PMID:36480329
|
Cancer cell line
|
Male |
M-G63, MG63 |
|
|
BTO:BTO_0001596,
CLO:CLO_0007699,
CLO:CLO_0007701,
CLO:CLO_0050808,
EFO:EFO_0002234,
MCCL:MCC:0000323,
CLDB:cl3462,
CLDB:cl3463,
CLDB:cl3464,
CLDB:cl3465,
CLDB:cl4934,
AddexBio:C0004007/4991,
ArrayExpress:E-MTAB-38,
ArrayExpress:E-MTAB-783,
ArrayExpress:E-MTAB-2706,
ArrayExpress:E-MTAB-2770,
ArrayExpress:E-MTAB-3610,
ATCC:CRL-1427,
BCRC:60279,
BCRJ:0173,
BioSample:SAMN03471910,
BioSample:SAMN03472771,
BioSample:SAMN10988146,
cancercelllines:CVCL_0426,
CCRID:1101HUM-PUMC000080,
CCRID:3101HUMTCHu124,
CCRID:4201HUM-CCTCC00074,
CCTCC:GDC0074,
Cell_Model_Passport:SIDM00525,
ChEMBL-Cells:CHEMBL3308498,
ChEMBL-Targets:CHEMBL614347,
CLS:300441,
Cosmic:755310,
Cosmic:908131,
Cosmic:931036,
Cosmic:931913,
Cosmic:1044085,
Cosmic:1070844,
Cosmic:1074394,
Cosmic:1082504,
Cosmic:1188475,
Cosmic:1529903,
Cosmic-CLP:908131,
DepMap:ACH-000359,
ECACC:86051601,
EGA:EGAS00001000610,
EGA:EGAS00001000978,
ENCODE:ENCBS091SUW,
ENCODE:ENCBS462PMF,
GDSC:908131,
GEO:GSM170251,
GEO:GSM320828,
GEO:GSM827317,
GEO:GSM879217,
GEO:GSM887314,
GEO:GSM888390,
GEO:GSM1670103,
GEO:GSM1915004,
GEO:GSM1915005,
GEO:GSM1915006,
GEO:GSM1915007,
GEO:GSM1915033,
GEO:GSM1915034,
GEO:GSM2635311,
GEO:GSM2635312,
IARC_TP53:21498,
IARC_TP53:21660,
ICLC:HTL99003,
IGRhCellID:MG63,
IZSLER:BS TCL 40,
JCRB:IFO50108,
KCB:KCB 200528YJ,
KCLB:21427,
LiGeA:CCLE_145,
LINCS_LDP:LCL-1428,
Lonza:872,
NCBI_Iran:C555,
PharmacoDB:MG63_924_2019,
PRIDE:PXD030304,
Progenetix:CVCL_0426,
PubChem_Cell_line:CVCL_0426,
RCB:RCB1890,
TKG:TKG 0294,
TOKU-E:2429,
Wikidata:Q54905408 |
|
|
CVCL_0426 |
2026-07-25 04:49:46 |
2522 |
PF-382
Resource Report
Resource Website
1+ mentions
|
RRID:CVCL_1641
|
Homo sapiens (Human)
|
Childhood T acute lymphoblastic leukemia
|
Population: Caucasian., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:2410652
PMID:3210814
PMID:3499548
PMID:15472075
PMID:15843827
PMID:16408098
PMID:17170727
PMID:20164919
PMID:22460905
PMID:26589293
PMID:27397505
PMID:30285677
PMID:30629668
PMID:30894373
PMID:31068700
PMID:35354797
PMID:35839778
|
Cancer cell line
|
Female |
PF382 |
|
|
CLO:CLO_0008421,
CLDB:cl3895,
CLDB:cl4993,
ArrayExpress:E-MTAB-783,
ArrayExpress:E-MTAB-2770,
ArrayExpress:E-MTAB-3610,
BioGRID_ORCS_Cell_line:487,
BioSample:SAMN03473327,
BioSample:SAMN10988497,
cancercelllines:CVCL_1641,
Cell_Model_Passport:SIDM00451,
ChEMBL-Cells:CHEMBL3308246,
ChEMBL-Targets:CHEMBL2366235,
Cosmic:909260,
Cosmic:913414,
Cosmic:1012113,
Cosmic:1115593,
Cosmic:1151790,
Cosmic:1224370,
Cosmic:1524814,
Cosmic:1641384,
Cosmic:2165708,
Cosmic-CLP:909260,
DepMap:ACH-000937,
DSMZ:ACC-38,
DSMZCellDive:ACC-38,
EGA:EGAS00001000978,
GDSC:909260,
GEO:GSM887513,
GEO:GSM888595,
GEO:GSM1670348,
GEO:GSM5137738,
IARC_TP53:21278,
ICLC:HTL00006,
LiGeA:CCLE_260,
LINCS_LDP:LCL-1021,
PharmacoDB:PF382_1262_2019,
PRIDE:PXD023662,
PRIDE:PXD030304,
Progenetix:CVCL_1641,
PubChem_Cell_line:CVCL_1641,
Wikidata:Q54947238 |
|
|
CVCL_1641 |
2026-07-25 04:59:04 |
3 |
PLC/PRF/5
Resource Report
Resource Website
500+ mentions
Discontinued
|
RRID:CVCL_0485
|
Homo sapiens (Human)
|
Adult hepatocellular carcinoma
|
Caution: Often called PLC8024 in Chinese literature probably because of a concatenation between PLC/PRF/5 and ATCC-8024., Karyotypic information: Has lost chromosome Y., Virology: Susceptible to infection by adenovirus types 40 (Ad40) and 41 (Ad41) (PubMed=1317878)., Virology: Contains at least 7 copies of integrated hepatitis B virus (HBV) genomes. Secretes hepatitis virus B surface antigen (HBsAg) but no other HBV proteins (PubMed=6302689; PubMed=6317496)., Population: African; Shangaan., Part of: MD Anderson Cell Lines Project., Part of: Liver Cancer Model Repository (LIMORE)., Part of: JFCR45 cancer cell line panel., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:63998
PMID:184551
PMID:187208
PMID:1317878
PMID:1661347
PMID:2414854
PMID:2439335
PMID:2542205
PMID:2992761
PMID:2992762
PMID:3023526
PMID:3431441
PMID:6160110
PMID:6225510
PMID:6248960
PMID:6268737
PMID:6275024
PMID:6288577
PMID:6302689
PMID:6317496
PMID:6555060
PMID:6889516
PMID:7874267
PMID:8050184
PMID:8224613
PMID:8389256
PMID:8835345
PMID:9023415
PMID:9178645
PMID:9290701
PMID:9359923
PMID:10523694
PMID:11050057
PMID:12029633
PMID:15767549
PMID:20069059
PMID:20164919
PMID:20215515
PMID:22460905
PMID:23505090
PMID:23887712
PMID:25485619
PMID:25574106
PMID:25877200
PMID:26589293
PMID:28196595
PMID:29892436
PMID:30894373
PMID:31063779
PMID:31068700
PMID:31378681
|
Cancer cell line
|
Male |
PLC-PRF-5, PLC PRF 5, PLC/PRF5, PLCPRF5, PLC-8024, PLC8024, PLC, Alexander cells, Alexander, Primary Liver Carcinoma/Poliomyelitis Research Foundation/5 |
|
|
BTO:BTO_0003492,
CLO:CLO_0008458,
CLO:CLO_0008459,
EFO:EFO_0006291,
MCCL:MCC:0000384,
CLDB:cl3914,
CLDB:cl3915,
CLDB:cl3916,
CLDB:cl5248,
ArrayExpress:E-MTAB-783,
ArrayExpress:E-MTAB-2706,
ArrayExpress:E-MTAB-2770,
ATCC:CRL-8024,
BCRC:60223,
BCRJ:0274,
BioGRID_ORCS_Cell_line:484,
BioSample:SAMN03471130,
BioSample:SAMN03473236,
BioSample:SAMN10988112,
cancercelllines:CVCL_0485,
CCRID:1101HUM-PUMC000674,
CCRID:1102HUM-NIFDC00071,
CCRID:3101HUMTCHu119,
CCRID:4201HUM-CCTCC00644,
Cell_Model_Passport:SIDM01318,
CGH-DB:9070-4,
ChEMBL-Cells:CHEMBL3308140,
ChEMBL-Targets:CHEMBL1075561,
CLS:300315,
Cosmic:721061,
Cosmic:808505,
Cosmic:871514,
Cosmic:873402,
Cosmic:925349,
Cosmic:945155,
Cosmic:948065,
Cosmic:1019318,
Cosmic:1351513,
Cosmic:1518224,
Cosmic:2023861,
Cosmic:2162538,
Cosmic:2321033,
Cosmic:2674231,
Cosmic:2773187,
DepMap:ACH-001318,
ECACC:85061113,
EGA:EGAS00001000610,
GDSC:925349,
GEO:GSM207051,
GEO:GSM565881,
GEO:GSM827153,
GEO:GSM886865,
GEO:GSM887520,
GEO:GSM887930,
GEO:GSM888602,
GEO:GSM936773,
GEO:GSM2551580,
GEO:GSM2551581,
IARC_TP53:107,
IARC_TP53:30016,
IZSLER:BS TCL 122,
JCRB:IFO50069,
JCRB:JCRB0406,
KCB:KCB 200785YJ,
KCLB:28024,
LiGeA:CCLE_292,
LIMORE:PLC8024,
LIMORE:PLCPRF5,
LINCS_LDP:LCL-1942,
NCBI_Iran:C145,
PharmacoDB:PLCPRF5_1274_2019,
Progenetix:CVCL_0485,
PubChem_Cell_line:CVCL_0485,
RCB:RCB1887,
TKG:TKG 0376,
TOKU-E:2898,
Ubigene:YC-C125,
Wikidata:Q54947574 |
|
|
CVCL_0485 |
2026-07-25 04:59:14 |
574 |
OVCAR-5
Resource Report
Resource Website
100+ mentions
Possibly Misclassified
|
RRID:CVCL_1628
|
Homo sapiens (Human)
|
High grade ovarian serous adenocarcinoma
|
Population: Caucasian., Part of: NCI-60 cancer cell line panel., Part of: MD Anderson Cell Lines Project., Part of: KuDOS 95 cell line panel., Part of: JFCR39 cancer cell line panel., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE)., Problematic cell line: Possibly misclassified. Originally thought to be a high grade ovarian serous adenocarcinoma but suspected to have a upper gastrointestinal origin (PubMed=27353327)..
|
PMID:1348364
PMID:2041050
PMID:2307530
PMID:3335022
PMID:3930572
PMID:6385258
PMID:7718330
PMID:9041185
PMID:9331090
PMID:10700174
PMID:12417041
PMID:12960427
PMID:15748285
PMID:17088437
PMID:19372543
PMID:19926575
PMID:20164919
PMID:20204287
PMID:22068913
PMID:22328975
PMID:22336246
PMID:22347499
PMID:22384151
PMID:22585861
PMID:22628656
PMID:22710073
PMID:23415752
PMID:23856246
PMID:23933261
PMID:24023729
PMID:24279929
PMID:24434149
PMID:24670534
PMID:25485619
PMID:25877200
PMID:26589293
PMID:27235858
PMID:27353327
PMID:27377824
PMID:27397505
PMID:27561551
PMID:27807467
PMID:28196595
PMID:28273451
PMID:30485824
PMID:30894373
PMID:30971826
PMID:31068700
PMID:31733513
PMID:35681748
PMID:35839778
PMID:38861359
|
Cancer cell line
|
Female |
OVCAR 5, NIH:OVCAR-5, OVCAR.5, OVCAR5, Ovcar5, OVCA5 |
|
|
BTO:BTO_0001870,
CLO:CLO_0008280,
EFO:EFO_0005443,
CLDB:cl3781,
ArrayExpress:E-MTAB-783,
ArrayExpress:E-MTAB-2706,
ArrayExpress:E-MTAB-3610,
BioGRID_ORCS_Cell_line:982,
BioSample:SAMN03472888,
BioSample:SAMN10989589,
cancercelllines:CVCL_1628,
Cell_Model_Passport:SIDM00091,
ChEMBL-Cells:CHEMBL3307565,
ChEMBL-Targets:CHEMBL614214,
CLS:305616,
Cosmic:875861,
Cosmic:897435,
Cosmic:905969,
Cosmic:974297,
Cosmic:1044241,
Cosmic:1092625,
Cosmic:1093554,
Cosmic:1102824,
Cosmic:1175885,
Cosmic:1305314,
Cosmic:1312356,
Cosmic:1436035,
Cosmic:1523763,
Cosmic:1707573,
Cosmic:1709255,
Cosmic:1995605,
Cosmic:1998467,
Cosmic:2186583,
Cosmic-CLP:905969,
DepMap:ACH-001151,
EGA:EGAS00001000610,
EGA:EGAS00001000978,
GDSC:905969,
GEO:GSM2126,
GEO:GSM50221,
GEO:GSM50285,
GEO:GSM185139,
GEO:GSM185140,
GEO:GSM659394,
GEO:GSM711709,
GEO:GSM743476,
GEO:GSM743493,
GEO:GSM743512,
GEO:GSM743513,
GEO:GSM743514,
GEO:GSM743515,
GEO:GSM743516,
GEO:GSM743517,
GEO:GSM743518,
GEO:GSM743519,
GEO:GSM743520,
GEO:GSM743521,
GEO:GSM743522,
GEO:GSM743523,
GEO:GSM743524,
GEO:GSM750830,
GEO:GSM784573,
GEO:GSM799365,
GEO:GSM799428,
GEO:GSM844671,
GEO:GSM847108,
GEO:GSM851936,
GEO:GSM1153437,
GEO:GSM1178525,
GEO:GSM1178526,
GEO:GSM1181280,
GEO:GSM1181287,
GEO:GSM1340587,
GEO:GSM1374802,
GEO:GSM1670319,
GEO:GSM2124678,
GEO:GSM2474993,
Millipore:SCC259,
NCI-DTP:OVCAR-5,
PharmacoDB:OVCAR5_1219_2019,
PRIDE:PXD003539,
PRIDE:PXD003668,
PRIDE:PXD005942,
PRIDE:PXD005946,
PRIDE:PXD030304,
Progenetix:CVCL_1628,
PubChem_Cell_line:CVCL_1628,
SKY/M-FISH/CGH:2818,
Wikidata:Q54937011 |
|
|
CVCL_1628 |
2026-07-25 04:58:05 |
209 |
OVCAR-3
Resource Report
Resource Website
1000+ mentions
Discontinued
|
RRID:CVCL_0465
|
Homo sapiens (Human)
|
High grade ovarian serous adenocarcinoma
|
Population: Caucasian., Part of: OCCP ovarian cancer cell line panel., Part of: NCI-60 cancer cell line panel., Part of: MD Anderson Cell Lines Project., Part of: KuDOS 95 cell line panel., Part of: JFCR39 cancer cell line panel., Part of: ENCODE project common cell types; tier 3., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE)., Part of: AKT genetic alteration cell panel (ATCC TCP-1029).
|
PMID:1348364
PMID:1892748
PMID:2041050
PMID:2307530
PMID:2653399
PMID:3335022
PMID:3930572
PMID:6372095
PMID:6385258
PMID:6604576
PMID:8557231
PMID:9041185
PMID:9331090
PMID:9698466
PMID:10700174
PMID:11414198
PMID:11793438
PMID:12417041
PMID:12960427
PMID:15748285
PMID:16382445
PMID:17088437
PMID:18277095
PMID:18560578
PMID:19372543
PMID:19926575
PMID:20164919
PMID:20204287
PMID:20215515
PMID:21912889
PMID:22068913
PMID:22328975
PMID:22336246
PMID:22347499
PMID:22384151
PMID:22460905
PMID:22585861
PMID:22628656
PMID:22710073
PMID:23172893
PMID:23351415
PMID:23415752
PMID:23839242
PMID:23856246
PMID:23933261
PMID:24023729
PMID:24279929
PMID:24434149
PMID:24670534
PMID:25230021
PMID:25485619
PMID:25877200
PMID:25984343
PMID:26169745
PMID:26589293
PMID:26972028
PMID:27141528
PMID:27235858
PMID:27377824
PMID:27397505
PMID:27561551
PMID:27807467
PMID:28100988
PMID:28196595
PMID:28273451
PMID:30485824
PMID:30894373
PMID:30971826
PMID:31068700
PMID:31733513
PMID:31978347
PMID:32612269
PMID:35839778
PMID:38861359
|
Cancer cell line
|
Female |
Ovcar-3, OVCAR 3, OVCAR.3, NIH:OVCAR-3, NIH:Ovcar-3, NIH:OVCAR3, NIH-OVCAR-3, NIHOVCAR3, OVCAR3, Ovcar3 |
|
|
BTO:BTO_0000812,
CLO:CLO_0008171,
CLO:CLO_0008279,
CLO:CLO_0051451,
EFO:EFO_0003061,
MCCL:MCC:0000363,
CLDB:cl3712,
CLDB:cl3780,
CLDB:cl5237,
Abcam:ab275471,
ArrayExpress:E-MTAB-38,
ArrayExpress:E-MTAB-783,
ArrayExpress:E-MTAB-2706,
ArrayExpress:E-MTAB-2770,
ArrayExpress:E-MTAB-3610,
ATCC:HTB-161,
BCRC:60551,
BCRJ:0317,
BioGRID_ORCS_Cell_line:981,
BioSample:SAMN01821585,
BioSample:SAMN03471390,
BioSample:SAMN05292457,
BioSample:SAMN10987888,
cancercelllines:CVCL_0465,
CCRID:1101HUM-PUMC000362,
CCRID:3101HUMTCHu228,
CCRID:4201HUM-CCTCC00119,
CCTCC:GDC0119,
Cell_Model_Passport:SIDM00105,
ChEMBL-Cells:CHEMBL3307564,
ChEMBL-Targets:CHEMBL614213,
CLS:300307,
Cosmic:687926,
Cosmic:688104,
Cosmic:755845,
Cosmic:809113,
Cosmic:844347,
Cosmic:845142,
Cosmic:875859,
Cosmic:897433,
Cosmic:905933,
Cosmic:906577,
Cosmic:920357,
Cosmic:924144,
Cosmic:927564,
Cosmic:949227,
Cosmic:974296,
Cosmic:991321,
Cosmic:1044239,
Cosmic:1092623,
Cosmic:1093553,
Cosmic:1102816,
Cosmic:1139222,
Cosmic:1175883,
Cosmic:1218877,
Cosmic:1305312,
Cosmic:1312192,
Cosmic:1312354,
Cosmic:1436033,
Cosmic:1482525,
Cosmic:1524357,
Cosmic:1709250,
Cosmic:1998465,
Cosmic:2186584,
Cosmic-CLP:905933,
DepMap:ACH-000001,
EGA:EGAS00001000610,
EGA:EGAS00001000978,
ENCODE:ENCBS419ENC,
GDSC:905933,
GEO:GSM2122,
GEO:GSM50219,
GEO:GSM50282,
GEO:GSM95463,
GEO:GSM185135,
GEO:GSM185136,
GEO:GSM274703,
GEO:GSM313683,
GEO:GSM459733,
GEO:GSM459741,
GEO:GSM645843,
GEO:GSM659393,
GEO:GSM711708,
GEO:GSM743474,
GEO:GSM743498,
GEO:GSM750817,
GEO:GSM784564,
GEO:GSM799362,
GEO:GSM799363,
GEO:GSM799425,
GEO:GSM799426,
GEO:GSM844668,
GEO:GSM847106,
GEO:GSM851934,
GEO:GSM887456,
GEO:GSM888536,
GEO:GSM1001493,
GEO:GSM1153434,
GEO:GSM1153435,
GEO:GSM1178508,
GEO:GSM1178509,
GEO:GSM1181276,
GEO:GSM1181278,
GEO:GSM1186813,
GEO:GSM1186814,
GEO:GSM1186815,
GEO:GSM1186816,
GEO:GSM1186827,
GEO:GSM1291149,
GEO:GSM1374771,
GEO:GSM1374772,
GEO:GSM1374773,
GEO:GSM1670317,
GEO:GSM2124645,
GEO:GSM2474989,
IARC_TP53:1417,
ICLC:HTL97004,
IGRhCellID:OVCAR3,
IZSLER:BS TCL 131,
KCB:KCB 2006106YJ,
KCLB:30161,
LiGeA:CCLE_502,
LINCS_LDP:LCL-1522,
Lonza:31,
MetaboLights:MTBLS150,
MetaboLights:MTBLS152,
Millipore:SCC257,
NCBI_Iran:C430,
NCI-DTP:OVCAR-3,
PharmacoDB:OVCAR3_1217_2019,
PRIDE:PXD003105,
PRIDE:PXD003539,
PRIDE:PXD003668,
PRIDE:PXD005942,
PRIDE:PXD005946,
PRIDE:PXD030304,
Progenetix:CVCL_0465,
PubChem_Cell_line:CVCL_0465,
RCB:RCB2135,
SKY/M-FISH/CGH:2742,
TKG:TKG 0602,
TOKU-E:2754,
Ubigene:YC-D019,
Wikidata:Q54937005 |
|
|
CVCL_0465 |
2026-07-25 04:58:05 |
1602 |
OVCAR-4
Resource Report
Resource Website
10+ mentions
|
RRID:CVCL_1627
|
Homo sapiens (Human)
|
High grade ovarian serous adenocarcinoma
|
Population: Caucasian., Part of: NCI-60 cancer cell line panel., Part of: MD Anderson Cell Lines Project., Part of: KuDOS 95 cell line panel., Part of: JFCR39 cancer cell line panel., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:1348364
PMID:2041050
PMID:2307530
PMID:3335022
PMID:3930572
PMID:6372095
PMID:6385258
PMID:7718330
PMID:9041185
PMID:9331090
PMID:10700174
PMID:12080474
PMID:12960427
PMID:15748285
PMID:17088437
PMID:19372543
PMID:20164919
PMID:22068913
PMID:22336246
PMID:22347499
PMID:22384151
PMID:22460905
PMID:22628656
PMID:23839242
PMID:23856246
PMID:23933261
PMID:24023729
PMID:24279929
PMID:24670534
PMID:25485619
PMID:25877200
PMID:25984343
PMID:26589293
PMID:27235858
PMID:27377824
PMID:27397505
PMID:27807467
PMID:28196595
PMID:30894373
PMID:30971826
PMID:31068700
PMID:31733513
PMID:31978347
PMID:32612269
PMID:35839778
PMID:35918200
PMID:38861359
|
Cancer cell line
|
Female |
OVCAR 4, NIH:OVCAR-4, NIH:OVCAR4, OVCAR.4, OVCAR4, Ovcar4 |
|
|
BTO:BTO_0002561,
CLO:CLO_0037096,
EFO:EFO_0005442,
ArrayExpress:E-MTAB-783,
ArrayExpress:E-MTAB-2706,
ArrayExpress:E-MTAB-2770,
ArrayExpress:E-MTAB-3610,
BioSample:SAMN03472889,
BioSample:SAMN10987768,
cancercelllines:CVCL_1627,
Cell_Model_Passport:SIDM00092,
ChEMBL-Cells:CHEMBL3307517,
ChEMBL-Targets:CHEMBL614051,
Cosmic:688105,
Cosmic:875860,
Cosmic:897434,
Cosmic:905990,
Cosmic:974295,
Cosmic:1044240,
Cosmic:1092624,
Cosmic:1175884,
Cosmic:1305313,
Cosmic:1312355,
Cosmic:1436034,
Cosmic:1998466,
Cosmic-CLP:905990,
DepMap:ACH-000617,
EGA:EGAS00001000610,
EGA:EGAS00001000978,
GDSC:905990,
GEO:GSM2174,
GEO:GSM50220,
GEO:GSM50284,
GEO:GSM185137,
GEO:GSM185138,
GEO:GSM186442,
GEO:GSM186443,
GEO:GSM743475,
GEO:GSM743494,
GEO:GSM750829,
GEO:GSM784572,
GEO:GSM799364,
GEO:GSM799427,
GEO:GSM844669,
GEO:GSM844670,
GEO:GSM847107,
GEO:GSM851935,
GEO:GSM887484,
GEO:GSM888565,
GEO:GSM1153436,
GEO:GSM1181279,
GEO:GSM1181286,
GEO:GSM1374801,
GEO:GSM1670318,
GEO:GSM2124646,
IARC_TP53:21085,
IARC_TP53:21126,
IARC_TP53:30217,
LiGeA:CCLE_876,
LINCS_LDP:LCL-1697,
Millipore:SCC258,
NCI-DTP:OVCAR-4,
PharmacoDB:OVCAR4_1218_2019,
PRIDE:PXD003539,
PRIDE:PXD005942,
PRIDE:PXD005946,
PRIDE:PXD030304,
Progenetix:CVCL_1627,
PubChem_Cell_line:CVCL_1627,
SKY/M-FISH/CGH:2817,
Wikidata:Q54937010 |
|
|
CVCL_1627 |
2026-07-25 04:58:05 |
44 |
P12-Ichikawa
Resource Report
Resource Website
|
RRID:CVCL_1630
|
Homo sapiens (Human)
|
Childhood T acute lymphoblastic leukemia
|
Population: Japanese., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:2985879
PMID:3159941
PMID:3874327
PMID:6582512
PMID:8127147
PMID:8641406
PMID:9933131
PMID:10071127
PMID:10739008
PMID:11226526
PMID:15472075
PMID:17170727
PMID:20164919
PMID:22460905
PMID:22675565
PMID:26589293
PMID:27397505
PMID:30285677
PMID:30629668
PMID:30894373
PMID:31068700
PMID:35354797
PMID:35839778
|
Cancer cell line
|
Male |
P12-ICHIKAWA, P12/ICHIKAWA, P12/Ichikawa, p12/Ichikawa, P12:ichikawa, P12ichikawa, P12ICHIKAWA, P12/ICH, P12/ICh, P12-ICH, P-12, P12 |
|
|
BTO:BTO_0002839,
CLO:CLO_0008298,
CLDB:cl3807,
ArrayExpress:E-MTAB-783,
ArrayExpress:E-MTAB-2770,
ArrayExpress:E-MTAB-3610,
BioSample:SAMN03473354,
BioSample:SAMN10988545,
cancercelllines:CVCL_1630,
Cell_Model_Passport:SIDM00463,
ChEMBL-Cells:CHEMBL3307676,
ChEMBL-Targets:CHEMBL614660,
Cosmic:721706,
Cosmic:909251,
Cosmic:913422,
Cosmic:933543,
Cosmic:1118465,
Cosmic:1151789,
Cosmic:1224371,
Cosmic:1281381,
Cosmic:1330492,
Cosmic:1375582,
Cosmic:1524812,
Cosmic:1641387,
Cosmic:1664526,
Cosmic:1760529,
Cosmic:2165715,
Cosmic:2602929,
Cosmic-CLP:909251,
DepMap:ACH-000372,
DSMZ:ACC-34,
DSMZCellDive:ACC-34,
EGA:EGAS00001000978,
GDSC:909251,
GEO:GSM887491,
GEO:GSM888573,
GEO:GSM1670326,
GEO:GSM5137735,
IARC_TP53:10568,
LiGeA:CCLE_538,
LINCS_LDP:LCL-1020,
PharmacoDB:P12ICHIKAWA_1230_2019,
PRIDE:PXD023662,
PRIDE:PXD030304,
Progenetix:CVCL_1630,
PubChem_Cell_line:CVCL_1630,
Wikidata:Q54937225 |
|
|
CVCL_1630 |
2026-07-25 04:58:08 |
0 |
Panc 08.13
Resource Report
Resource Website
1+ mentions
|
RRID:CVCL_1638
|
Homo sapiens (Human)
|
Pancreatic ductal adenocarcinoma
|
Population: Caucasian., From: Johns Hopkins University School of Medicine; Baltimore; USA., Part of: NCI RAS program mutant KRAS cell line panel., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:9612602
PMID:14695172
PMID:16912165
PMID:18000365
PMID:20164919
PMID:20215515
PMID:22460905
PMID:22585861
PMID:22753594
PMID:25167228
PMID:25485619
PMID:25877200
PMID:25984343
PMID:26589293
PMID:27259358
PMID:27397505
PMID:29444439
PMID:30894373
PMID:30971826
PMID:31068700
PMID:35839778
|
Cancer cell line
|
Male |
Panc 8.13, Panc-08.13, PANC-08-13, Panc_08_13, Panc08.13, Panc8.13, Panc-8_13, Panc-813, PANC 813, Panc813, PANC813, PANC0813, Panc0813, Pa14C, PL9, PL-9 |
|
|
CLO:CLO_0008379,
EFO:EFO_0006470,
ArrayExpress:E-MTAB-783,
ArrayExpress:E-MTAB-2706,
ArrayExpress:E-MTAB-2770,
ArrayExpress:E-MTAB-3610,
ATCC:CRL-2551,
BioGRID_ORCS_Cell_line:189,
BioSample:SAMN03472947,
BioSample:SAMN10988145,
cancercelllines:CVCL_1638,
Cell_Model_Passport:SIDM01136,
ChEMBL-Cells:CHEMBL3308777,
ChEMBL-Targets:CHEMBL1075558,
Cosmic:925347,
Cosmic:949526,
Cosmic:1198215,
Cosmic:1198221,
Cosmic:1473126,
Cosmic:1509858,
Cosmic:2434104,
Cosmic-CLP:925347,
DepMap:ACH-000417,
EGA:EGAS00001000610,
EGA:EGAS00001000978,
GDSC:925347,
GEO:GSM206531,
GEO:GSM621905,
GEO:GSM784709,
GEO:GSM827278,
GEO:GSM887499,
GEO:GSM888581,
GEO:GSM1024410,
GEO:GSM1374813,
GEO:GSM1670334,
LiGeA:CCLE_501,
LINCS_LDP:LCL-1742,
PharmacoDB:Panc08_13_1244_2019,
PRIDE:PXD003198,
PRIDE:PXD030304,
Progenetix:CVCL_1638,
PubChem_Cell_line:CVCL_1638,
Wikidata:Q54937528 |
|
|
CVCL_1638 |
2026-07-25 04:58:15 |
9 |
Panc 03.27
Resource Report
Resource Website
10+ mentions
|
RRID:CVCL_1635
|
Homo sapiens (Human)
|
Pancreatic adenocarcinoma
|
Population: Caucasian., From: Johns Hopkins University School of Medicine; Baltimore; USA., Part of: TCGA-110-CL cell line panel., Part of: RAS genetic alteration cell panel (ATCC TCP-1031)., Part of: NCI RAS program mutant KRAS cell line panel., Part of: MD Anderson Cell Lines Project., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:9612602
PMID:14695172
PMID:16912165
PMID:18000365
PMID:19305140
PMID:20037478
PMID:20164919
PMID:22460905
PMID:22585861
PMID:25167228
PMID:25485619
PMID:25877200
PMID:25984343
PMID:26216984
PMID:26589293
PMID:27259358
PMID:27397505
PMID:28196595
PMID:29444439
PMID:30894373
PMID:30971826
PMID:31068700
PMID:31395879
PMID:35839778
|
Cancer cell line
|
Female |
Panc 3.27, Panc-03.27, PANC-03-27, Panc_03_27, Panc-3_27, PANC3.27, Panc3.27, Panc3_27, Panc-327, PANC 327, Panc327, PANC0327, Panc0327, PL11, PL-11 |
|
|
CLO:CLO_0008376,
EFO:EFO_0006467,
ArrayExpress:E-MTAB-783,
ArrayExpress:E-MTAB-2706,
ArrayExpress:E-MTAB-2770,
ArrayExpress:E-MTAB-3610,
ATCC:CRL-2549,
BioGRID_ORCS_Cell_line:188,
BioSample:SAMN03473169,
BioSample:SAMN10988317,
cancercelllines:CVCL_1635,
Cell_Model_Passport:SIDM01138,
ChEMBL-Cells:CHEMBL3308124,
ChEMBL-Targets:CHEMBL1075557,
Cosmic:925346,
Cosmic:949522,
Cosmic:1198222,
Cosmic:2434102,
Cosmic-CLP:925346,
DepMap:ACH-000139,
EGA:EGAS00001000610,
EGA:EGAS00001000978,
GDSC:925346,
GEO:GSM206528,
GEO:GSM621904,
GEO:GSM784705,
GEO:GSM887496,
GEO:GSM888578,
GEO:GSM1024407,
GEO:GSM1374811,
GEO:GSM1670332,
IARC_TP53:27226,
LiGeA:CCLE_371,
LINCS_LDP:LCL-1740,
PharmacoDB:Panc03_27_1241_2019,
PRIDE:PXD003198,
PRIDE:PXD030304,
Progenetix:CVCL_1635,
PubChem_Cell_line:CVCL_1635,
Wikidata:Q54937517 |
|
|
CVCL_1635 |
2026-07-25 04:58:14 |
10 |
